What health system execs are talking aboutnews2026-07-16T16:10:38+00:00July 16th, 2026|Endpoints News|
Kelun pads efficacy profile of Merck-partnered ADC; Europe will have to wait for Boehringer’s Hernexeosnews2026-07-16T15:18:38+00:00July 16th, 2026|Endpoints News|
Q&A: Betty Tijms wants to stop treating Alzheimer’s as a single diseasenews2026-07-16T14:53:37+00:00July 16th, 2026|Endpoints News|
US drug shortages rise for third straight quarter, hurt by lone suppliersnews2026-07-16T14:13:57+00:00July 16th, 2026|Endpoints News|
Updated: Sanofi, Arbutus file separate suits against mRNA vaccine makers over LNP tech patentsnews2026-07-16T11:35:38+00:00July 16th, 2026|Endpoints News|
Lilly bets $2.8B upfront on psychedelics in deal to buy AtaiBeckleynews2026-07-16T11:09:28+00:00July 16th, 2026|Endpoints News|
Merck beats AstraZeneca to first approval for first PCSK9 pillnews2026-07-16T10:45:08+00:00July 16th, 2026|Endpoints News|
FDA acting chief walks back Makary’s practice of policymaking through journalsnews2026-07-15T19:21:40+00:00July 15th, 2026|Endpoints News|
Senate committee questions CDC pick on political interference over vaccinesnews2026-07-15T18:46:12+00:00July 15th, 2026|Endpoints News|
J&J restructures pharma manufacturing footprint at cost of up to $750M news2026-07-15T16:48:54+00:00July 15th, 2026|Endpoints News|
